Pankaj Jaiswal, 28, suffering from an advanced stage of colorectal cancer (commonly known as bowel cancer) got a new lease of life after doctors from Dr LH Hiranandani Hospital performed a rare surgery with a new technology.
Pankaj Jaiswal, 28, suffering from an advanced stage of colorectal cancer (commonly known as bowel cancer) got a new lease of life after doctors from Dr LH Hiranandani Hospital performed a rare surgery with a new technology.
The cytoreductive surgery and the hyperthermic intra-peritonial chemotherapy (HIPEC) provides a new ray of hope for people suffering from cancer of the large intestine, ovary and appendix.
Jaiswal found out that he had cancer after he noticed some abnormalities.
“I saw some blood in the stools, following which my abdomen started bloating and I lost weight, which was alarming. Doctors said I had cancer in the rectum. After a laparoscopy, they found that it had spread to other areas of the abdominal cavity.”
After consulting a few hospitals, Jaiswal landed at Hiranandani Hospital. “The family was already counselled that the only treatment available was palliative chemotherapy, which would decrease the symptoms and control the disease for a short period,” said Dr Sanket Mehta, oncosurgeon, Hiranandani Hospital, Powai.
The procedure is expected to relieve patients’ suffering from advanced stage of abdominal cancers like ovarian cancers, pseudomyxomas (cancers arising from the appendix), mesothiliomas and primary peritoneal cancers. Traditional treatment methods have not yielded good results in such critical conditions.
“We started with an aggressive type of chemotherapy involving three types of chemotherapy drugs that gave a good response, which is an encouraging sign. After evaluation, he was taken up for a surgery where we removed all the disease and then administered a heated chemotherapy bath directly into the abdomen, called HIPEC, using a special machine that delivers this chemotherapy at high concentration, high flow rate and a high temperature. The combination of this aggressive surgery and HIPEC can offer this patient a potential chance of long-term survival,” said Dr Mehta.
The cancer in appendix, large intestine and ovaries has a tendency to spread to the entire peritoneum — a membrane that lines the inside of abdomen and envelops all the organs in the abdomen. “The present protocol for such patients is plain chemotherapy, which isn’y much effective and the patient has a very poor life,” said Dr Mehta.
According to experts, a significant number of patients with pseudomyxomas can survive for up to 10 years and there is even a good chance of cure. HIPEC is not only effective for pseudomyxomas but also for mesotheliomas (primary cancer of peritoneum), colorectal cancers and ovarian cancers with peritoneal spread.
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
)
){kind=small}
){kind=small}
)
)
)
)
)
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}